Your browser doesn't support javascript.
loading
Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk.
Müller-Wieland, Dirk; Leiter, Lawrence A; Cariou, Bertrand; Letierce, Alexia; Colhoun, Helen M; Del Prato, Stefano; Henry, Robert R; Tinahones, Francisco J; Aurand, Lisa; Maroni, Jaman; Ray, Kausik K; Bujas-Bobanovic, Maja.
Afiliação
  • Müller-Wieland D; Department of Internal Medicine I, University Hospital Aachen, Pauwelsstr. 30, 52074, Aachen, Germany. dirmueller@ukaachen.de.
  • Leiter LA; Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Cariou B; Institut du Thorax, CHU Nantes, Nantes, France.
  • Letierce A; Biostatistics and Programming Department, Sanofi, Chilly-Mazarin, France.
  • Colhoun HM; University of Edinburgh, Edinburgh, Scotland, UK.
  • Del Prato S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Henry RR; University of California San Diego School of Medicine, Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, CA, USA.
  • Tinahones FJ; CIBERobn, Hospital Virgen de la Victoria, Málaga University, Málaga, Spain.
  • Aurand L; Sanofi, Bridgewater, NJ, USA.
  • Maroni J; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
  • Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, London, UK.
  • Bujas-Bobanovic M; Sanofi, Paris, France.
Cardiovasc Diabetol ; 16(1): 70, 2017 05 25.
Article em En | MEDLINE | ID: mdl-28545518

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colesterol / Diabetes Mellitus Tipo 2 / Hiperlipoproteinemia Tipo V / Anticorpos Monoclonais / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Cardiovasc Diabetol Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colesterol / Diabetes Mellitus Tipo 2 / Hiperlipoproteinemia Tipo V / Anticorpos Monoclonais / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Cardiovasc Diabetol Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha